Feng Zhang (張鋒), a 2016 Tang Prize winner, explained his latest genome editing tool, called CRISPR/Cas13, in a meeting Wednesday with Tang Prize Foundation CEO Chern Jenn-chuan (陳振川) and a Nobel Prize laureate in Physiology or Medicine at the Massachusetts Institute of Technology (MIT).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
TISA system launched to strengthen citizen financial planning
06/30/2025 10:28 PM - Business
Meta fined NT$15 million for lack of transparency about advertisers
06/30/2025 09:21 PM - Cross-Strait
3 sentenced for holding political events in Taiwan with Chinese funds
06/30/2025 08:05 PM - Culture
Golden Bell Award-winning TV show host, writer Wang Hao-yi dies at 68
06/30/2025 07:35 PM - Culture
National Railway Museum to partially open July 31: Culture ministry
06/30/2025 06:42 PM